Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more
Release Date:
Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 21, 2023 issue.
Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more